SPIE Photonics West Digital Forum Showcases Best of Optics, Photonics, Quantum, Biomedical Technologies in Applications and Research
17.3.2021 19:08:00 EET | Business Wire | Press release
SPIE, the international society for optics and photonics, welcomed an engaged global audience to its SPIE Photonics West Digital Forum 6-11 March with 8,000 registered attendees. Across the highly regarded BiOS, LASE, and OPTO symposia, as well as the new industry-focused Quantum West conference, SPIE Photonics West showcased more than 20 plenary speakers, including Ursula Keller, Gérard Mourou, Susumu Noda, Satoshi Kako, Kohji Mitani, Sheila Nirenberg, Laura Fabris, and Yeka Aponte. More than 100 live events – including panel sessions, technical discussions, and networking events complemented the 3,200 on-demand presentations.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210317005651/en/
SPIE Photonics West Digital Forum showcases best of optics, photonics, quantum, biomedical technologies in applications and research (Photo: Business Wire)
In addition, two Digital Marketplaces – one for Photonics West, one for BiOS – together showcased more than 400 exhibitors and over 100 product demonstrations of the latest innovations in optics and photonics.
The largest photonics virtual event of 2021, SPIE Photonics West spotlighted and recognized the best optics and photonics technologies, trends, and entrepreneurial innovations, offering many opportunities for attendees, presenters, scientists, and engineers to engage and discuss their latest research and work. From COVID-focused diagnostics advancements and neuro-technologies to lasers in manufacturing and data center communications, SPIE Photonics West offered a dynamic week of information sharing, learning, and conversation.
Quantum West, a new conference on quantum technology held in partnership with the QED-C, featured industry leaders such as Celia Merzbacher, Peter Knight, Andrew Lord, Wilhelm Kaenders, and Kaitlin Moore exploring the role of photonics in quantum technology’s growth from R&D into engineering products for commercial applications.
"I have worked with SPIE over many years, as both an exhibitor and conference chair, and am very happy to help build Quantum West together with them,” said Quantum West Co-Chair Tim Day who serves as DRS Daylight Solutions GM and senior VP, as well as Member of the Board of ColdQuanta. “SPIE did a great job under challenging circumstances and is always a wonderful partner in terms of bringing the community together and helping to advance photonics technology. We, along with many others in the photonics community, are looking forward to an in-person meeting next January in San Francisco.”
Other industry-focused events featured live sessions with thought leaders discussing today’s hottest application areas, including industrial lasers, sensing and imaging, and autonomous vehicles.
“I come to Photonics West every year with my students,” said Jennifer Barton, who is co-chair for BiOS as well as the director of the University of Arizona’s BIO5 Institute and the university’s Thomas R. Brown Distinguished Professor of Biomedical Engineering. “This year, three of them presented virtually, along with myself. I was very impressed with the high quality of live and prerecorded presentations, the flawless execution of events, and the surprisingly effective opportunities for networking and fun – go Trivia Night! Of course, I am looking forward to seeing everyone in person next year, but I loved how engaging and informative this conference week was.”
“Photonics West is the largest biomedical, laser, and optoelectronic event in our field, even when we cannot travel,” noted SPIE Senior Director of Technical Programs Marilyn Gorsuch. “Given the virtual circumstances, our volunteer conference chairs rolled up their sleeves and produced an amazing offering to present and discuss the latest technical advancements. But nothing can replace the in-person experience and the excitement of gathering together at Photonics West in San Francisco. We are very much looking forward to hosting Photonics West in San Francisco next January.”
All the Photonics West content will be available on the SPIE Digital Library from 20 March.
Photonics West 2022 will take place 22-27 January at the Moscone Center in San Francisco. The Call for Papers will be announced and open in the next few weeks.
About SPIE
SPIE is the international society for optics and photonics, an educational not-for-profit organization founded in 1955 to advance light-based science, engineering, and technology. The Society serves more than 258,000 constituents from 184 countries, offering conferences and their published proceedings, continuing education, books, journals, and the SPIE Digital Library. In 2020, SPIE provided over $5 million in community support including scholarships and awards, outreach and advocacy programs, travel grants, public policy, and educational resources. www.spie.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210317005651/en/
Contact information
Daneet Steffens
Public Relations Manager
daneets@spie.org
+1 360 685 5478
@SPIEtweets
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 11:22:00 EET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz ® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 23:42:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meury, President and Chief Executive Officer, Incyte. “As the first PD-1 immunotherapy approved in Europe in combination with platinum-based chemotherapy in the first-line setting, Zynyz helps expand the standard-of-care options available to clinicians and underscores our commitment to delivering innovative medicines that can have an impact for patients.” The EC decision follows the January 2026 positive opinion received from the European Medicines Agency’s Committee f
Dfns Launches Payouts6.3.2026 22:27:00 EET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 21:23:00 EET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 19:30:00 EET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom